English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Clinical Trials
애질렉스 바이오랩스와 B2S 생명과학, 임상실험용 면역 분석법 바이오 분석에 대한 중요 주제 공유
Apr 29, 2021 08:00 HKT
Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials
Apr 29, 2021 04:00 HKT
Agilex Biolabs收购领先的Biolab TetraQ作为APAC扩展计划的一部分
Apr 07, 2021 15:00 HKT
Agilex Biolabs收購領先的Biolab TetraQ作為APAC擴展計劃的一部分
Apr 07, 2021 15:00 HKT
TrialWire launches StudyBoost, the Clinical Trial Insurance Plan
Mar 24, 2021 05:00 HKT
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
Jan 28, 2021 07:00 HKT
Penanda aras baru yang akan memberikan penjagaan osteoporosis yang optimum ke seluruh Asia Pasifik
Jan 28, 2021 01:30 HKT
최적의 골다공증 케어를 위한 새로운 아시아태평양 벤치마크 설정
Jan 28, 2021 01:30 HKT
新标准的设立将为整个亚太地区提供最佳的骨质疏松症医疗管理
Jan 28, 2021 01:30 HKT
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
Jan 28, 2021 01:30 HKT
Azelis significantly increases its market presence in Vietnam through the acquisition of a majority shareholding in MKVN Chemicals and Viet Chemi
Jan 05, 2021 14:35 HKT
Sự hiện diện của Azelis trên thị trường Việt Nam đã được củng cố sâu sắc sau thương vụ thu mua đa số cổ phần tại MKVN Chemicals và Viet Chemi
Jan 05, 2021 14:30 HKT
AIM ImmunoTech宣布其药物Ampligen的ME/CFS临床试验已开始接受COVID-19长期患者的注册
Dec 24, 2020 21:00 HKT
AIM ImmunoTech宣布其藥物Ampligen的ME/CFS臨床試驗已開始接受COVID-19長期患者的註冊
Dec 24, 2020 21:00 HKT
Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002
Nov 12, 2020 15:00 HKT
Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma - announced at Bio-Europe 2020
Oct 28, 2020 00:03 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: